Streptococcus pneumoniae in the potential effects of new vaccines on the pattern of antibiotic drug usage in pediatrics

Current Therapeutic Research - Clinical and Experimental

Volumn 63, Issue 10, 2002, Pages 695-706

  Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antibiotic; Resistance; Streptococcus pneumoniae; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGENICITY; BACTERIAL COLONIZATION; CONFERENCE PAPER; DAY CARE; DISEASE CARRIER; HUMAN; OTITIS MEDIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0036810119     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(02)80074-1     Document Type: Conference Paper

References (19)

1. Appelbaum PC. Resistance among Streptococcous pneumoniae: Implications for drug selection. Clin Infect Dis. 2002;34:1613-1620.
2. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: Herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J. 2000;19(5 Suppl):S79-S88.
3. Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J. 2000;19(5 Suppl):S57-S65.
4. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996;174:1271-1278.
5. Dagan R, Muallem M, Melamed R, et al. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J. 1997; 16:1060-1064.
6. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet. 1996;348:271-272. Letter.
7. Mbelle N, Huebner RE, Wasas AD, et al. Immunogenicity and impact on nasopharyngeal carriage of a nonvalent pneumococcal conjugate vaccine. J Infect Dis. 1999;180: 1171-1176.
8. Kristinsson KG, Sigurdardottir ST, Gudnason T, et al. Effect of vaccination with octavalent protein conjugated pneumococcal vaccines on pneumococcal carriage in infants. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1997:193. Abstract G-5.
9. Edwards KM, Wandling G, Palmer P, et al. Carriage of pneumococci among infants immunized with a 9-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age. 37th Annual Meeting of the Infectious Diseases Society of America. Alexandria, Va: Infectious Diseases Society of America; 1999:966. Abstract 44.
10. Dagan R, Zamir O, Tirosh N, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in toddlers vaccinated during infancy with an 11-valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2000:236. Abstract 47.
11. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185:927-936.
12. 9). Paper presented at: 18th Annual Meeting of the European Society for Paediatric Infectious Diseases; May 3-5, 2000; Noordwijk, The Netherlands.
13. O'Brien KL, Bronsdon M, Carlone GM, et al. Effect of a seven valent pneumococcal conjugate vaccine on nasopharyngeal (NP) carriage among native American infants. Ped Res. 2001;49(Suppl):256A. Abstract 1463.
14. Dagan R, Sikuler-Cohen M, Zamir O, et al. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 2001;20:951-958.
15. Dagan R, Givon-Lavi N, Porat N, et al. Immunization of toddlers attending day care centers with a 9-valent conjugate pneumococcal vaccine reduces transmission of Streptococcus pneumoniae and antibiotic resistant S. pneumoniae to their young siblings. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 2000:244. Abstract 687.
16. Black S. Paper presented at: 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; March 26-28, 2001; Istanbul, Turkey.
17. Dagan R, Givon-Lavi N, Shkolnik L, et al. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: Implication for immunizing with conjugate vaccines. J Infect Dis. 2000; 181:1322-1329.
18. Joloba ML, Windau A, Bajaksouzian S, et al. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis. 2001;33:1489-1494.
19. Block SL, Hedrick JA, Harrison CJ. Pneumococcal serotypes from acute otitis media in rural Kentucky. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1999: 677. Abstract 1185.